408 A potent and selective small molecule inhibitor of MCL-1 sensitizes DLBCL cell lines to the BCL-2 selective inhibitor ABT-199 von Phillips, D.C, Xiao, Y, Lam, L, Litinovic, E, Roberts-Rapp, L, Souers, A.J, Leverson, J.D

Volltext

The Bcl-2 specific BH3 mimetic ABT-199: a promising targeted therapy for t(11;14) multiple myeloma von Touzeau, C, Dousset, C, Le Gouill, S, Sampath, D, Leverson, J D, Souers, A J, Maïga, S, Béné, M C, Moreau, P, Pellat-Deceunynck, C, Amiot, M

Volltext

PS06.02 Drug-Tolerant EGFR Mutant Lung Cancer Cells Rely on MCL-1 Translation and are Eliminated by MCL-1 Inhibitors: Topic: Pulmonology von Song, K., Lochmann, T.L., Patel, N.U., Ham, J., Windle, B.E., Harada, H., Leverson, J.D., Souers, A.J., Ebi, H., Faber, A.C.

Volltext

PS06.02 Drug-Tolerant EGFR Mutant Lung Cancer Cells Rely on MCL-1 Translation and are Eliminated by MCL-1 Inhibitors von Song, K., Lochmann, T.L., Patel, N.U., Ham, J., Windle, B.E., Harada, H., Leverson, J.D., Souers, A.J., Ebi, H., Faber, A.C.

Volltext